| |
| |
|
| Insider
Information: |
Jacob Gary S |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
792,866 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,954 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
792,866 |
|
|
| Total
Value |
$48,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Callisto Pharmaceuticals Inc |
CLSP |
Chief Executive Office... |
2007-10-23 |
147,425 |
|
0 |
Premium* |
|
|
Synergy Pharmaceuticals Inc (FL) |
SGYP |
Executive Chairman, Di... |
2018-06-15 |
595,460 |
|
0 |
Premium* |
|
|
Cardiff Oncology Inc |
CRDF |
Director |
2021-03-23 |
21,922 |
|
0 |
Premium* |
|
|
Hepion Pharmaceuticals, Inc |
HEPA |
Director |
2020-12-01 |
12,059 |
2014-02-18 |
0 |
Premium* |
|
|
Virpax Pharmaceuticals, Inc. |
VRPX |
Director |
2021-02-17 |
3,500 |
2021-02-17 |
0 |
Premium* |
|
|
Okyo Pharma Ltd |
OKYO |
Chief Executive Office... |
2022-05-19 |
12,500 |
2022-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OKYO |
Okyo Pharma Ltd |
Chief Executive Officer |
• • – |
2022-05-19 |
4 |
B |
$4.00 |
$50,000 |
D/D |
12,500 |
12,500 |
2.81 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-23 |
4 |
B |
$10.40 |
$24,689 |
D/D |
2,370 |
21,922 |
2.39 |
- |
|
| VRPX |
Virpax Pharmaceuticals, I... |
Director |
– • – |
2021-02-17 |
4 |
B |
$6.79 |
$23,762 |
D/D |
3,500 |
3,500 |
2.39 |
- |
|
| HEPA |
Hepion Pharmaceuticals, I... |
Director |
– • – |
2020-12-01 |
4 |
B |
$1.66 |
$19,920 |
D/D |
12,000 |
12,059 |
2.39 |
% |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-05-14 |
4 |
B |
$1.43 |
$25,001 |
D/D |
17,483 |
19,552 |
2.39 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Executive Chairman |
• • – |
2018-06-15 |
4 |
OE |
$0.50 |
$237,481 |
D/D |
474,961 |
877,640 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Executive Chairman |
• • – |
2018-06-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(282,180) |
595,460 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
148,954 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2017-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,287 |
132,287 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-05-26 |
4 |
B |
$3.52 |
$19,967 |
D/D |
5,680 |
402,679 |
2.81 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-07-01 |
4 |
OE |
$5.61 |
$353,234 |
D/D |
62,965 |
396,999 |
0 |
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-05-27 |
4 |
B |
$4.18 |
$16,720 |
D/D |
4,000 |
338,034 |
2.81 |
- |
|
| HEPA |
Hepion Pharmaceuticals, I... |
CEO and President |
• • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
32,935 |
32,935 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2012-01-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
738,000 |
|
- |
|
| SGYP |
Synergy Pharmaceuticals I... |
CEO and PresidentOfficer |
• • – |
2011-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
374,939 |
|
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2007-10-23 |
4 |
A |
$0.49 |
$6,125 |
D/D |
12,500 |
147,425 |
0 |
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Chief Executive Officer |
– • – |
2006-08-21 |
4 |
B |
$0.84 |
$4,200 |
D/D |
5,000 |
134,745 |
2.31 |
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2005-06-16 |
4 |
B |
$1.00 |
$5,000 |
D/D |
5,000 |
129,745 |
2.81 |
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2005-03-09 |
4 |
B |
$1.52 |
$25,001 |
D/D |
16,448 |
124,745 |
2.81 |
- |
|
| CLSP |
Callisto Pharmaceuticals ... |
Chief Executive OfficerOfficer |
• • – |
2004-10-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
108,297 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
